Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes

by Nichole E. Brunton, Waldemar E. Wysokinski, David O. Hodge, Danielle T. Vlazny, Damon E. Houghton, Ana I. Casanegra
Published 2021-05-01

Prognostic significance of patent foramen ovale in anticoagulated patients with atrial fibrillation

by Bernard J Gersh, Jae K Oh, Waldemar E Wysokinski, Zhenzhen Wang, Samuel J Asirvatham, Sri Harsha Patlolla, Eddie L Greene, Hon-Chi Lee
Published 2020-06-01

Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients

by Rahul Chaudhary, MD, MBA, Jalaj Garg, MD, Damon E. Houghton, MD, M. Hassan Murad, MD, Ashok Kondur, MD, Rohit Chaudhary, MS, Waldemar E. Wysokinski, MD, Robert D. McBane, II, MD
Published 2021-04-01

In-home Compared With In-Clinic Warfarin Therapy Monitoring in Mechanical Heart Valves: A Population-Based Study

by Martin van Zyl, MB, ChB, Waldemar E. Wysokinski, MD, PhD, Thomas M. Jaeger, MD, Ana I. Casanegra, MD, Bernard J. Gersh, MB, ChB, DPhil, Robert D. McBane, II, MD
Published 2020-10-01

Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation

by Waldemar E. Wysokinski, MD, PhD, Rowlens M. Melduni, MD, MPH, Naser M. Ammash, MD, Danielle T. Vlazny, PA-C, MS, Ewa Konik, MD, Rayya A. Saadiq, DO, Izabela Gosk-Bierska, MD, Joshua Slusser, BS, Diane Grill, MS, Robert D. McBane, MD
Published 2021-03-01

Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism

by Julia C. Cambron, BS, Elias S. Saba, BS, Robert D. McBane, MD, Ana I. Casanegra, MD, Hector R. Villarraga, MD, Damon E. Houghton, MD, Danielle T. Vlazny, PA-C, MS, David Froehling, MD, David Hodge, MS, Lisa G. Peterson, MAN, RN, Dalene M. Bott-Kitslaar, APRN, CNP, Waldemar E. Wysokinski, MD, PhD
Published 2020-06-01